Jaruga P, Kant M, Dizdaroglu M
ACS Omega. 2025; 10(1):1519-1530.
PMID: 39829548
PMC: 11740632.
DOI: 10.1021/acsomega.4c09310.
He Z, Qiu W, Zhou H
Commun Biol. 2025; 8(1):40.
PMID: 39799263
PMC: 11724883.
DOI: 10.1038/s42003-025-07467-4.
Wang X, Ma X, Chen S, Fan M, Jin C, Chen Y
Front Immunol. 2024; 15:1517604.
PMID: 39687616
PMC: 11647001.
DOI: 10.3389/fimmu.2024.1517604.
Zheng X, Liu B, Ni P, Cai L, Shi X, Ke Z
Ann Med. 2024; 57(1):2437046.
PMID: 39648715
PMC: 11632943.
DOI: 10.1080/07853890.2024.2437046.
Wen J, Zhu Q, Liu Y, Gou L
Acta Biochim Biophys Sin (Shanghai). 2024; 57(1):33-58.
PMID: 39574165
PMC: 11802351.
DOI: 10.3724/abbs.2024201.
Past, Present, and Future of RNA Modifications in Infectious Disease Research.
Pan X, Bruch A, Blango M
ACS Infect Dis. 2024; 10(12):4017-4029.
PMID: 39569943
PMC: 11651297.
DOI: 10.1021/acsinfecdis.4c00598.
Epigenetic modifications in hematopoietic ecosystem: a key tuner from homeostasis to acute myeloid leukemia.
Yao S, Guo R, Tian W, Zheng Y, Hu J, Han G
Blood Sci. 2024; 6(4):e00206.
PMID: 39281854
PMC: 11398801.
DOI: 10.1097/BS9.0000000000000206.
MYC Drives mRNA Pseudouridylation to Mitigate Proliferation-Induced Cellular Stress during Cancer Development.
Ding J, Bansal M, Cao Y, Ye B, Mao R, Gupta A
Cancer Res. 2024; 84(23):4031-4048.
PMID: 39240686
PMC: 11609627.
DOI: 10.1158/0008-5472.CAN-24-1102.
Promoted Read-through and Mutation Against Pseudouridine-CMC by an Evolved Reverse Transcriptase.
He Z, Qiu W, Zhou H
bioRxiv. 2024; .
PMID: 39005393
PMC: 11244976.
DOI: 10.1101/2024.07.03.601893.
SnoRNAs: Exploring Their Implication in Human Diseases.
Chauhan W, Sj S, Kafle S, Zennadi R
Int J Mol Sci. 2024; 25(13).
PMID: 39000310
PMC: 11240930.
DOI: 10.3390/ijms25137202.
Prognostic signature and immune efficacy of mA-, mC-, mA-, mG-, and DNA methylation-related regulators in hepatocellular carcinoma.
Liu D, Zhou X, Zhao J
J Cancer. 2024; 15(13):4287-4300.
PMID: 38947378
PMC: 11212094.
DOI: 10.7150/jca.95730.
Single-molecule epitranscriptomic analysis of full-length HIV-1 RNAs reveals functional roles of site-specific mAs.
Baek A, Lee G, Golconda S, Rayhan A, Manganaris A, Chen S
Nat Microbiol. 2024; 9(5):1340-1355.
PMID: 38605174
PMC: 11087264.
DOI: 10.1038/s41564-024-01638-5.
Heterogeneity of chemical modifications on RNA.
Goh W, Kuang Y
Biophys Rev. 2024; 16(1):79-87.
PMID: 38495447
PMC: 10937866.
DOI: 10.1007/s12551-023-01128-8.
RNA modifications in gynecological cancer: current status and future directions.
He W, Hong X, Chen G, Luo X, Lin Y
Front Med (Lausanne). 2024; 11:1314075.
PMID: 38343637
PMC: 10853395.
DOI: 10.3389/fmed.2024.1314075.
Mapping mA Sites on HIV-1 RNA Using Oligonucleotide LC-MS/MS.
Baek A, Rayhan A, Lee G, Golconda S, Yu H, Kim S
Methods Protoc. 2024; 7(1).
PMID: 38251200
PMC: 10801558.
DOI: 10.3390/mps7010007.
N-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis.
Weng H, Huang H, Chen J
Adv Exp Med Biol. 2024; 1442:105-123.
PMID: 38228961
DOI: 10.1007/978-981-99-7471-9_7.
RNA Modifications in Hematologic Malignancies.
Li Y, Tian W, Zhang H
Cancer Treat Res. 2023; 190:181-207.
PMID: 38113002
DOI: 10.1007/978-3-031-45654-1_6.
RNA Modifications in Cancer Metabolism and Tumor Microenvironment.
Qing Y, Wu D, Deng X, Chen J, Su R
Cancer Treat Res. 2023; 190:3-24.
PMID: 38112997
DOI: 10.1007/978-3-031-45654-1_1.
The structural basis of mRNA recognition and binding by yeast pseudouridine synthase PUS1.
Grunberg S, Doyle L, Wolf E, Dai N, Correa Jr I, Yigit E
PLoS One. 2023; 18(11):e0291267.
PMID: 37939088
PMC: 10631681.
DOI: 10.1371/journal.pone.0291267.
Interconnections between mA RNA modification, RNA structure, and protein-RNA complex assembly.
Hofler S, Duss O
Life Sci Alliance. 2023; 7(1).
PMID: 37935465
PMC: 10629537.
DOI: 10.26508/lsa.202302240.
